MedPath

HPV Self-test to Increase Cervical Cancer Screening in Asian Women

Not Applicable
Completed
Conditions
Cervical Cancer
Registration Number
NCT04612660
Lead Sponsor
Temple University
Brief Summary

The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the preventable infection-related cervical cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
156
Inclusion Criteria
  1. gender: female
  2. age: 30-55
  3. no current diagnosis of cervical cancer, and
  4. have not participated in cervical cancer screening within the past 3 years.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
the change in the rate of cervical cancer screeningbaseline, and 6-month follow up
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center for Asian Health, Lewis Katz School of Medicine, Temple University

🇺🇸

Philadelphia, Pennsylvania, United States

Center for Asian Health, Lewis Katz School of Medicine, Temple University
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.